Comparative evaluation between ascorbic acid and N-acetyl cysteine for preventing tourniquet induced ischaemic reperfusion injury during lower limb surgery, a randomized controlled trial  by Mohamed, Mahmoud Hassan & Hamawy, Tamer Yosef
Egyptian Journal of Anaesthesia (2016) 32, 103–109HO ST E D  BY
Egyptian Society of Anesthesiologists
Egyptian Journal of Anaesthesia
www.elsevier.com/locate/egja
www.sciencedirect.comResearch ArticleComparative evaluation between ascorbic acid and
N-acetyl cysteine for preventing tourniquet induced
ischaemic reperfusion injury during lower limb
surgery, a randomized controlled trial* Corresponding author at: Department of Anesthesiology, Faculty of Medicine, Ain Shams University, Egypt. Tel.: +20 01009882538
E-mail address: mahmoudhasan33@gmail.com (M.H. Mohamed).
1 Tel.: +20 01223160725.
Peer review under responsibility of Egyptian Society of Anesthesiologists.
http://dx.doi.org/10.1016/j.egja.2015.07.003
1110-1849  2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.Mahmoud Hassan Mohamed *, Tamer Yosef Hamawy 1Department of Anesthesiology, Faculty of Medicine, Ain Shams University, EgyptReceived 28 November 2014; revised 26 June 2015; accepted 27 July 2015





IschemiaAbstract Background: During tourniquet induced ischemic reperfusion, reactive oxygen species
and cytokines appear and cause cellular damage and remote tissue injury.
Aim: To compare the effects of preoperative intravenous infusion of N-acetyl cysteine or ascorbic
acid on the production of malonyldialdehyde as a marker of oxidative stress and IL-6 and IL-8 as
markers of systemic inflammation after ischemic reperfusion as primary outcomes. Also both agents
were compared regarding post-deflation hemodynamic effects and post-deflation changes in arterial
pH and lactic acid as secondary outcomes.
Patient and methods: 60 patients, scheduled for unilateral lower extremity surgery with a pneumatic
tourniquet, were included. The study was designed as a randomized controlled parallel arms supe-
riority trial. Baseline collection of blood samples was done and then patients were randomly clas-
sified into three groups: Group A; received 1 g Ascorbic acid, group N; received 10 mg/kg NAC and
group C (control group): received 100 ml saline infusion. Epidural anesthesia was administrated.
Two blood samples were drawn at each assessment time. One sample for arterial blood pH and lac-
tic acid measurement and the other blood sample was centrifuged and stored at 20 C for subse-
quent analysis of MDA, IL-6 and IL-8.
Results: Levels of MDA, IL-6, and IL-8 were significantly increased in group C after tourniquet
release compared with the baseline. In groups A and N, MDA did not increase over baseline values,
but IL-6 and IL-8 levels were increased and their levels were significantly less than in the control group..
104 M.H. Mohamed, T.Y. HamawyChanges in hemodynamics, pH and serum lactate weremore evident in groupC than groupsA andN.
Conclusion: BothN-acetyl cysteine and ascorbic acid reduce post-deflation increase in blood levels of
markers of oxidative stress and markers of systemic inflammation and thus both are beneficial in pre-
venting post-tourniquet deflation ischemic reperfusion injury in lower limb surgery.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Application of proximal pneumatic tourniquet is widely used
in extremity surgeries to control intraoperative bleeding. Ischemia
occurs following tourniquet inflation, and reperfusion occurs
after deflation because of the re-establishment of blood flow
[1]. The hemodynamic and metabolic effects that occur with
tourniquet application depend on the duration of tourniquet
placement, size of the ischemic area, type of anesthesia, and
the cardiovascular condition of the patient [2]. Sequestration
of oxygenated blood cells in the extremity during ischemia
leads to the appearance of free oxygen radicals [3]. With the
event of reperfusion, the Reactive Oxygen Species (ROS) and
cytokines appear and cause damage to cellular structures
through the process of the lipid peroxidation of cellular mem-
branes and macromolecules [4]. The Cellular damage that
occurs after reperfusion of previously viable ischemic tissue
is defined as ischemic reperfusion (IR) injury [5]. Antioxidant
medications and/or cytokine-modulating therapies might,
therefore, reduce morbidity [6]. Lipid peroxidation represents
a chain reaction leading to oxidation of polyunsaturated fatty
acids, disrupting membrane structure and producing toxic
metabolites such as malonyldialdehyde (MDA) which is used
as a sensitive marker of ischemic reperfusion injury [7]. Inter-
leukin 6 (IL-6), which is reliable indicator of systemic inflam-
mation, also correlates with the extent of reperfusion injury
[8]. IL-6 has been correlated with the activation of circulating
neutrophil and potential tissue injury [9]. Circulating IL-8 has
also been implicated with the process of lower limb ischemia–
reperfusion injury which may cause neutrophil sequestration
and increased microvascular permeability especially in the lung
[10]. N-acetyl cysteine (NAC), an n-acetyl derivative of the
amino acid L-cysteine, is a thiol-containing compound which
has been widely used for many years as a mucolytic drug in
the treatment of chronic obstructive pulmonary disease. It also
has antioxidant, cytoprotective and microcirculatory effects
[11]. Its pharmacological actions include restoration of cellular
antioxidant potential by restoration of depleted glutathione,
direct scavenging of oxygen-free radicals, and inhibition of
neutrophil activity and TNF production [12]. Vitamin C, also
known as ascorbic acid, is a water-soluble antioxidant
molecule that removes the aqueous phase oxygen free radicals
by a rapid electron transfer and inhibits oxidative damage to
important biological macromolecules, including DNA,
proteins, and lipids [13].
In this prospective, double blind, placebo controlled study
we compared the effects of preoperative intravenous infusion
of N-acetyl cysteine or Ascorbic acid on the production of
MDA as a marker of oxidative stress and IL-6 and IL-8 as
markers of systemic inflammation after tourniquet induced
ischemic reperfusion injury during lower limb surgery as pri-
mary outcomes. Also we compared both agents regardingpost-deflation hemodynamic effects by comparing total doses
of ephedrine consumed and post-deflation changes in arterial
pH and lactic acid levels as secondary outcomes.2. Patients and methods
After approval of the hospital ethics committee and written
informed consent, 60 patients ASA physical status I or II, aged
25–45 years, scheduled for unilateral lower extremity surgery
with a pneumatic tourniquet for a duration of 60–90 min, were
included in this study. Exclusion criteria included the presence
of vascular disease, cardiorespiratory disease, renal insuffi-
ciency, liver dysfunction, diabetes or the administration of
any antioxidant or anti-inflammatory drug.
No premedication was given.Warm fluids were given to con-
trol the mean arterial blood pressure and temperature within
normal ranges throughout the study. The study was designed
as a randomized controlled parallel arms superiority trial. Base-
line collection of blood samples (T0) was done and then sealed,
and opaque envelopes containing a computer-generated ran-
dom sequence were used for randomization of three groups.
Randomization type was simple and the randomization code
was concealed until the end of the trial and analysis of data.
Group A (Ascorbic acid group): N= 20, received 1 g vita-
min C (Ascorbic acid) dissolved in 100 mL 0.9% normal saline
intravenously infused within one hour. Group N (N-acetyl
cysteine group): N= 20 N received 10 mg/kg NAC dissolved
in 100 mL 0.9% normal saline intravenously infused within
one hour and Group C (control group): N= 20 received the
same volume of saline (100 mL) infused intravenously within
one hour as a placebo.
After infusion of the study drugs, epidural anesthesia was
administrated at the L2–L3 or L3–L4 interspace using 0.5%
bupivacaine. The sensory block level was kept below T10 (in
order to minimize the hypotensive effect of epidural anesthesia
as possible). The lower extremity was exsanguinated and a
pneumatic tourniquet was inflated to a pressure of approxi-
mately twice the systolic blood pressure. All operations were
performed in the supine position.
Intraoperative arterial blood pressure values of 20% less
than basal were considered hypotensive. Intravenous bolus
(IV) ephedrine 3 mg was administered as a bolus in the setting
of hypotension followed by 1 mg increments to restore baseline
blood pressure. When intraoperative bleeding occurred,
volume replacement was initiated with saline instead of blood
products. The patient demographics, the tourniquet times,
volume of local anesthetic and the dosages of ephedrine were
recorded. Two blood samples were drawn at each assessment
time, at baseline (T0), 1 min after tourniquet placement (T1),
1 min before tourniquet release (T2), 5 min after tourniquet
release (T3), 20 min ATR (T4) and 1 h ATR (after tourniquet
Table 1 Demographic and operative data.
Variable Group A (N= 20) Group N (N= 20) Group C (N= 20) p-value
Male/Female 11/9 10/10 11/9 0.935
Age (years) 36 (6) 35 (8) 35 (7) 0.875
BMI (kg/m2) 23.8 (2.7) 24.2 (2.5) 23.9 (2.6) 0.880
Surgical procedure 0.360
Fixation of tibial fracture 8 (40%) 8 (40%) 9 (45%)
Fixation of ankle fracture 8 (40%) 9 (45%) 8 (40%)
Knee arthroscopic 4 (20%) 3 (15%) 3 (15%)
Local anesthetic volume (ml) 12.5 (1.4) 12.4 (1.5) 12.3 (1.3) 0.904
Level of sensory block T11 (T10–T12) 20 (100%) 20 (100%) 20 (100%) 0.958
Tourniquet time (min) 74 (13) 75 (14) 77 (11) 0.751
Data are presented as ratio, mean (SD), number (%), or median (interquartile range).
BMI, body mass index.
Table 2 Assays of plasma malonyldialdehyde and serum interleukins levels.
Variable Time Group A (n= 20) Group N (n= 20) Group C (n= 20) p-value
MDA (nmol/l) T0 2.9 (0.7) 3.0 (0.8) 2.8 (0.9) 0.735
T1 3.0 (0.6) 3.0 (0.7) 2.9 (0.8) 0.875
T2 2.7 (0.9) 2.8 (0.8) 2.8 (0.8) 0.909
T3 3.0 (0.7) 2.9 (0.8) 6.1 (0.4)a <0.0001
T4 2.9 (0.7) 3.0 (0.8) 5.8 (0.8)a <0.0001
T5 2.9 (0.7) 3.0 (0.8) 5.5 (0.8)a <0.0001
IL-6 (pg/ml) T0 2.7 (0.8) 2.8 (0.7) 2.9 (0.7) 0.692
T1 3.4 (0.7) 3.3 (0.6) 3.4 (0.6) 0.848
T2 3.9 (0.60 4.1 (0.4) 4.0 (0.5) 0.464
T3 6.8 (0.5) 6.7 (0.6) 12.3 (0.8)a <0.0001
T4 6.4 (0.7) 6.5 (0.9) 13.2 (0.8)a <0.0001
T5 5.3 (0.6) 5.4 (0.8) 13.3 (0.6)a <0.0001
IL-8 (pg/ml) T0 11.6 (0.7) 11.7 (0.6) 11.8 (0.8) 0.670
T1 11.5 (0.7) 11.5 (0.6) 11.4 (0.6) 0.848
T2 11.7 (0.5) 11.3 (0.6) 11.0 (0.5) 0.0005
T3 16.8 (0.80 16.7 (0.6) 32.3 (0.7)a <0.0001
T4 15.4 (0.6) 15.5 (0.7) 33.2 (0.7)a <0.0001
T5 15.2 (0.5) 14.9 (0.6) 33.6 (0.6)a <0.0001
Data are presented as mean (SD).
IL-6, interleukin-6; IL-8, interleukin-8; MDA, malonyldialdehyde; T0, baseline (T0); T1, 1 min after tourniquet placement; T2, 1 min before
tourniquet release; T3, 5 min after tourniquet release; T4, 20 min after tourniquet release; T5, 1 h after tourniquet release.
a p-value < 0.001 vs. Group A and Group N.
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tate measurement and the other blood sample were centrifuged
to separate the serum and plasma, which were then stored at
20 C for subsequent analysis of MDA, IL-6 and IL-8.
The plasma MDA was analyzed by the method of thiobar-
bituric acid reaction (Jiancheng Bio-engineering Research
Institute, Nanjing, China); IL-6 and IL-8 were determined
using enzyme linked immunosorbent assay with kits (Jingmei
Sciences Co., Ltd., Shenzhen, China) according to manufac-
turer’s instructions.
To maintain the double blind nature of the study, an anes-
thesia resident who was not present during the patients’ group
allocation and tourniquet application collected data and ana-
lyzed blood gas. Circulating mediators were analyzed by inves-
tigators who were unaware of the patients’ group assignment
and the blood gas results.3. Statistical methods
Statistical analysis was done using GraphPad Prism for
Windows version 6 and GraphPad Instat version 3.05
(GraphPad Software, Inc., San Diego California, USA).
It was estimated that a sample of 20 patients per group
would have a power of 86% to detect a large effect size of
f= 0.45 as regards the primary outcome (production of
malonyldialdehyde, IL-6 and IL-8) measures using the F-test
and assuming a two-sided type I error of 0.05.
Continuous numerical variables were presented as mean
(SD) and intergroup comparisons were done using one-way
analysis of variance (ANOVA) with the use of the Tukey–
Kramer test for post hoc comparisons. Discrete variables were
presented as median (interquartile range) and the Kruskal–
Wallis test was used for comparison of the groups. Categorical








Total dose of ephedrine before tourniquet release (mg) 10.2 (3.3) 9.9 (4.1) 10.1 (3.8) 0.967
Total dose of ephedrine after tourniquet release (mg) 4.3 (1.4) 4.1 (1.5) 7.6 (2.0)a <0.0001
Data are presented as mean (SD).
a P-value < 0.001 versus Group A and Group N.
Figure 1 Changes in pH in the three study groups. Error bars
represent SD. T0, baseline (T0); T1, 1 min after tourniquet
placement; T2, 1 min before tourniquet release; T3, 5 min after
tourniquet release; T4, 20 min after tourniquet release; T5, 1 h
after tourniquet release.
Figure 2 Changes in serum lactate in the three study groups.
Error bars represent SD. T0, baseline (T0); T1, 1 min after
tourniquet placement; T2, 1 min before tourniquet release; T3,
5 min after tourniquet release; T4, 20 min after tourniquet release;
T5, 1 h after tourniquet release.
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chi square test was used to test between-group differences.
4. Results
All 60 patients who were included completed the study. As is
shown in Table 1, there were no differences between the 3
groups as regards the demographic data. The types of surgical
procedures were comparable in the 3 groups as well as were the
tourniquet time, the upper level of sensory block, and the vol-
ume of local anesthetic used.In the control group (C), MDA, IL-6, and IL-8 levels were
significantly increased at T3, T4 and T5 after release of the
tourniquet compared with the baseline (p-value < 0.0001). In
groups (A and N), MDA did not increase over baseline values.
IL-6 and IL-8 levels were increased in both groups (A and N)
at T3, T4 and T5 after release of the tourniquet, but their levels
were significantly less than in the control group (Table 2).
There was no difference between the three groups compar-
ing the total dose of ephedrine used to control the blood pres-
sure before tourniquet release, while there were significant
differences between the three groups as regards the total dose
of ephedrine used to control blood pressure after tourniquet
release (ATR) (p-value < 0.0001) (Table 3). In group C there
was more consumption of ephedrine than the other two
groups.
Figs. 1 and 2 show pH and lactic acid values in the 3 groups
at different observation times. There were a decrease in pH
and an increase in serum lactate at T4 and T5 only in group
(C) when compared with the other 2 groups.
5. Discussion
The aim of our study was to compare the effects of preopera-
tive intravenous infusion of N-acetyl cysteine or Ascorbic acid
on the production of MDA as a marker of oxidative stress and
IL-6 and IL-8 as markers of systemic inflammation after
tourniquet induced ischemic reperfusion injury during lower
limb surgery as primary outcomes. Also we compared both
agents regarding post-deflation hemodynamic effects by com-
paring total doses of ephedrine consumed and post-deflation
changes in arterial pH and serum lactate as secondary
outcomes.
During tourniquet induced ischemia, cells cannot maintain
their membrane integrity, which releases calcium and phos-
pholipid A2 as well as formation of polyunsaturated fatty
acids and fatty acid radicals [14]. With reperfusion, fatty acid
radicals react with oxygen, triggering lipid peroxidation, which
is an autocatalytic mechanism leading to oxidative destruction
of cell membranes that increases membrane permeability and
stimulates leukocyte chemotaxis with the production of
toxic reactive metabolites and cell death [15]. Thus, oxygen
derived free radicals and proteolytic enzymes are released
from the cells and these materials damage the cells in remote
tissues. Consequently, amino acid modifications including
8-hydroxydeoxyguanosine, carbonyls, methionine sulphoxide
and MDA are produced. Those oxygen-free radicals or lipid
peroxides are short lived and difficult to measure directly.
MDA is a more stable degradation product of lipid peroxides,
is often assayed, and is believed to reflect the lipid peroxidation
level [16]. A significant increase in the level of MDA has
been observed in the lung tissue and in plasma of patients
Figure 3 Participant‘s flow diagram.
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which is a reliable indicator of systemic inflammation, also cor-
relates with the extent of reperfusion injury and has also been
associated with the activation of circulating neutrophil and
potential tissue injury [8,9]. Circulating IL-8 has also been
implicated in the process of lower limb ischemia–reperfusion
injury by a mechanism suggested to involve neutrophil seques-
tration and increased microvascular permeability in the lung
[19,10]. The correlations of the increased levels of MDA,
IL-6, and IL-8 with the hemodynamic and blood gas variables
in our study support the hypothesis that lipid peroxidation and
systemic inflammatory response may play a role in ischemic
reperfusion injury after tourniquet induced lower limb
ischemia.
The results of our study showed that the use of preoperative
N-acetyl cysteine or ascorbic acid decreased the production of
MDA, IL-6 and IL-8 during reperfusion after tourniquet
induced ischemia, also during the post-inflation period, and
there were more stable hemodynamics and no changes in pH
or lactic acid levels with the use of these two drugs.
The reduction of the harmful effects of reperfusion injury
has been investigated through different approaches including
the following: anesthetic techniques [20], preconditioning [21]
and drugs as ketamine [22], dexmedetomidine [23] or propofol
[24].
NAC is an antioxidant which reacts strongly with the
hydroxyl radical and with hypochloric acid, but reacts poorly
with the hydrogen peroxide and superoxide radicals. It may
also have an indirect antioxidant effect by facilitatingglutathione biosynthesis and supplying GSH for glutathione
peroxidase catalyzed reactions [25]. A study done by Nagasaki
and co-workers showed that in glutathione-depleted liver,
NAC prevents hepatic injury and improves liver integrity after
I/R injury, as a direct free-radical scavenger not by acting as a
substrate for glutathione synthesis [26]. Low-dose N-acetyl
cysteine infusion (5 mg/kg/h) was found to attenuate lipid per-
oxidation and IR injury in arthroscopic knee surgery requiring
tourniquet application [27]. In a study conducted by Koca and
his co-workers, NAC and ischemic preconditioning were
found to have protective effect on the occurrence of oxidative
stress resulting from IR period by preventing MDA, super
oxide dismutase glutathione peroxidase, total antioxidant
capacity, and total oxidant status changes in routine arthro-
scopic knee surgery [28].
Vitamin C, also known as ascorbic acid, is a potent water
soluble natural antioxidant that quenches ROS and inhibits
ROS mediated nitric oxide inactivation. In addition, vitamin
C can act as coantioxidant by regenerating other antioxidants
[29].
Nightingale et al. found that in patients with cardiac
failure, nitric oxide (NO) bioavailability increased in the brain
stem and blood vessels after intravenous infusion of high-dose
vitamin C, leading to improvements in blood vessel distensibil-
ity and baroreceptor reflex function. They also reported that
this phenomenon directly prevented free oxygen radicals from
suppressing the baroreceptors. Oxidative stress regulates NO
metabolism in the brain stem and is, therefore, involved in
baroreceptor reflex regulation. This might maintain the
108 M.H. Mohamed, T.Y. Hamawyvascular resistance and baroreceptor reflex and, as a result,
mean arterial pressure could also be maintained with the use
of high-dose vitamin C [30].
Clinically, the antioxidant effect of vitamin C has been
studied in some surgical models. A study done by Dingchao
et al., reported that MDA, creatinine phosphokinase (CPK-
MB) and lactate dehydrogenase (LDH) levels decreased
following the administration of high-dose vitamin C in patients
undergoing open heart surgery which may offer some protec-
tion for cardiac muscle [31].
In a study conducted by Basili et al., they reported that in
patients undergoing elective percutaneous coronary interven-
tion, vitamin C infusion blunted in vivo the increase of 2
markers of oxidative stress, namely (8-OHdG) 8-hydroxy-20-
deoxyguanosine and 8-iso-prostaglandin F2alpha (F2-IPs)
with concomitant improvement of thrombolysis in myocardial
infarction (myocardial perfusion grade) [32].
Another study showed that vitamin C infusion before per-
cutaneous coronary intervention (PCI) was associated with a
lower incidence of PMI (Periprocedural myocardial injury).
The investigators suggested that the cardioprotective effect of
vitamin C may result from the inhibition of oxidative stress
[33].
Administering high-dose vitamin C to elderly patients
undergoing bilateral total knee replacement (TKR) surgery
could lower MDA levels and prevent the unstable hemody-
namics and hypoxia caused by IR injury in both knees,
decreasing the incidence of both cardiopulmonary complica-
tion and mortality rates [34].
In conclusion, the results of our study showed that both
N-acetyl cysteine and vitamin C (ascorbic acid) reduce post-
deflation increase in blood levels of markers of oxidative stress
and markers of systemic inflammation and thus both are
beneficial in preventing post-tourniquet deflation ischemic
reperfusion injury in lower limb surgery.6. Limitations of the study
There were no limitations of the study.Conflict of interest
No conflict of interests.References
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